Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
KCultivator Q&A: April Boyd-Noronha opens up on access to technology, authentic change
Editor’s note: KCultivators is a lighthearted profile series to highlight people who are meaningfully enriching Kansas City’s entrepreneurial ecosystem. The KCultivator Series is sponsored by WeWork Corrigan Station, a modern twist on Kansas City office space.Awakening education and business potential while in your pajamas is an unexpected side effect of rapid technological advancement, said April…
KC Pinoy parks restaurant in West Bottoms, plans fiesta of Filipino flavors
KC Pinoy’s new spot on Genessee Street in the West Bottoms was an opportunity that just fell into Chrissy Nucum’s lap, said the owner of the Filipino food truck turned brick-and-mortar restaurant. “I wanted something where there’s a sense of community within whatever area we choose,” said Nucum. “When the West Bottoms Kitchen decided to…
Curb appeal attracts investors to $850K round for real estate tech firm RealQuantum
A year of steady growth will help Kansas City real estate tech firm RealQuantum end 2018 with the close of its first round of seed funding — securing $850,000 in investments, revealed Mark Davis. “We closed a couple of times actually — people just kept showing up at the last minute wanting in,” Davis, RealQuantum’s…
Battery Tour energizes Sunshine Boxes with global vision to power developing economies through music
AY Young’s recent Battery Tour generated enough money to send two of 17° 73° Innovation Co’s Sunshine Boxes to Haiti — the first step in a partnership between the two ventures with common goals, the energetic founder said. “[We] just realized that we were trying to kind of do the same thing as far as…